Summary

CSL (2026CSL) is a biotechnology company focused on developing and commercializing innovative therapies for kidney diseases, including anemia associated with chronic kidney disease and hematopoietic stem cell transplantation. Their primary product is Epogee®, a phosphate binder, and they are actively developing other therapies targeting various aspects of kidney and blood disorders. The company’s research and development efforts are centered around improving patient outcomes and quality of life for individuals living with these conditions.

Title

CSL Behring Saudi Arabia

Description

CSL Behring Saudi Arabia

Keywords

rights, english

NS Lookup

A 12.3.33.221

Dates

Created 2026-02-15

Updated 2026-02-15

Summarized 2026-03-18